F FIERCE PHARMA
LIVE

Serial Number

98923826

Owner

QUESTEX, LLC

Attorney

Deborah J. Peckham

First Use Date

Jun 5, 2020

Filing Date

Dec 26, 2024

Add to watchlist:

No watchlists yet
View on USPTO

F FIERCE PHARMA Trademark

Serial Number: 98923826 • Registration: 8074264

F FIERCE PHARMA is a trademark filed by QUESTEX, LLC on December 26, 2024. The trademark is classified under Class 41 (Education & Entertainment), Class 42 (Computer & Scientific), Class 35 (Advertising & Business). The application is currently registered and active.

Owner Contact Info

QUESTEX, LLC (85 trademarks)

275 GROVE STREET
NEWTON, MA 02466

Entity Type: 16

Trademark Details

Filing Date

December 26, 2024

Registration Date

December 23, 2025

First Use Anywhere

June 5, 2020

First Use in Commerce

June 5, 2020

Published for Opposition

November 4, 2025

Goods & Services

Providing medical and scientific research information and news in the fields of pharmaceuticals, drug development, cell and gene therapy, and drug manufacturing

Conducting, arranging, promoting and organizing trade shows, business expos and buyer events for business purposes in the fields of pharmaceuticals, drug policy, drug development, cell and gene therapy, drug manufacturing and drug regulations; providing public policy information in the field of drugs

Arranging and conducting in-person educational forums, educational meetings, conferences, and conventions in the fields of pharmaceuticals, drug policy, drug development, cell and gene therapy, drug manufacturing and drug regulations; educational services, namely, arranging and conducting educational conferences, seminars and workshops in the fields of pharmaceuticals, drug policy, drug development, cell and gene therapy, drug manufacturing and drug regulations; providing information and news in the fields of pharmaceuticals, drug policy, drug development, cell and gene therapy, drug manufacturing and drug regulations; providing online, non-downloadable newsletters in the fields of pharmaceuticals, drug development, cell and gene therapy, drug manufacturing and drug regulations; conducting of business conferences in the field of pharmaceuticals, drug policy, drug development, cell and gene therapy, drug manufacturing and drug regulations

Filing History

NOTICE OF REGISTRATION CONFIRMATION EMAILED
Dec 23, 2025 NRCC
REGISTERED-PRINCIPAL REGISTER
Dec 23, 2025 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Nov 4, 2025 NPUB
PUBLISHED FOR OPPOSITION
Nov 4, 2025 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Oct 29, 2025 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Oct 1, 2025 CNSA
EXAMINER'S AMENDMENT ENTERED
Sep 22, 2025 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Sep 22, 2025 GNEN
EXAMINERS AMENDMENT E-MAILED
Sep 22, 2025 GNEA
EXAMINERS AMENDMENT -WRITTEN
Sep 22, 2025 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
Sep 11, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Sep 11, 2025 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Sep 11, 2025 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jun 11, 2025 GNRN
NON-FINAL ACTION E-MAILED
Jun 11, 2025 GNRT
NON-FINAL ACTION WRITTEN
Jun 11, 2025 CNRT
ASSIGNED TO EXAMINER
Jun 5, 2025 DOCK
NOTICE OF DESIGN SEARCH CODE E-MAILED
May 27, 2025 MDSM
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
May 27, 2025 NWOS
NEW APPLICATION ENTERED
Dec 26, 2024 NWAP